Expert Consensus

Consensus on integrative medicine cooling therapy management during the peri-chemotherapy period for breast cancer

  • Huan LIN ,
  • Hongsheng LI ,
  • Mei HUANG ,
  • Guochun ZHANG ,
  • Neng WANG ,
  • Guanqun HUANG ,
  • Juan XU ,
  • Qingfeng ZOU ,
  • Xingyuan SHI ,
  • Wenguang HE ,
  • Feng LI ,
  • Yanqing CAI ,
  • xiaoping HUANG ,
  • Qiongdiao HUANG ,
  • Zejuan YANG ,
  • Runmei LUO ,
  • Jiewen ZHANG ,
  • Yi TANG ,
  • Chaoliang XU ,
  • Hongfei GAO ,
  • Weicai CHEN ,
  • Hao HU ,
  • Yongsheng YAO ,
  • Chu HUANG ,
  • Jiewen HUANG ,
  • Yichao HUANG ,
  • Yeyan LEI ,
  • Ming LUO ,
  • Zhe WU ,
  • Nangui YUAN ,
  • Yongting LIN
Expand

Received date: 2025-11-08

  Online published: 2026-03-09

Abstract

Breast cancer stands as one of the most prevalent malignant tumors among women globally. Chemotherapy, being a crucial element in breast cancer treatment, is frequently linked to diverse side-effects, including alopecia and hand-foot syndrome. These adverse reactions can significantly undermine patients' psychological health and quality of life. In response to this issue, international research has indicated that cooling therapy can effectively decrease the incidence of alopecia; however, 16% to 84% of patients still encounter hair loss. Clinical practice has proven that combining traditional Chinese medicine with chemotherapy in breast cancer treatment can further reduce the incidence of alopecia and hand-foot syndrome, relieve patient discomfort, improve the quality of life, and offer chemosensitizing and efficacy-enhancing effects. Nevertheless, there is a deficiency of standardized protocols in practical applications. To further standardize and optimize clinical practice, a multidisciplinary expert panel consisting of breast oncology specialists, oncological traditional Chinese medicine experts, and nursing science professionals was assembled. After multiple rounds of deliberation and revision, this consensus document was finally formulated. This consensus standardizes Integrative Medicine Cooling Therapy Management from multiple perspectives, such as scope, terminology and definitions, theoretical bases, implementation procedures, characteristic TCM therapies, and efficacy assessment. It especially emphasizes the implementation procedures during chemotherapy and characteristic TCM treatment methods. The document puts forward seven evidence-based recommendations to offer standardized guidance for clinical practice.

Cite this article

Huan LIN , Hongsheng LI , Mei HUANG , Guochun ZHANG , Neng WANG , Guanqun HUANG , Juan XU , Qingfeng ZOU , Xingyuan SHI , Wenguang HE , Feng LI , Yanqing CAI , xiaoping HUANG , Qiongdiao HUANG , Zejuan YANG , Runmei LUO , Jiewen ZHANG , Yi TANG , Chaoliang XU , Hongfei GAO , Weicai CHEN , Hao HU , Yongsheng YAO , Chu HUANG , Jiewen HUANG , Yichao HUANG , Yeyan LEI , Ming LUO , Zhe WU , Nangui YUAN , Yongting LIN . Consensus on integrative medicine cooling therapy management during the peri-chemotherapy period for breast cancer[J]. The Journal of Practical Medicine, 2026 , 42(5) : 723 -733 . DOI: 10.3969/j.issn.1006-5725.2026.05.001

References

[1] ROSE L, LUSTBERG M, RUDDY K J, et al. Hair loss during and after breast cancer therapy[J]. Support Care Cancer, 2023,31(3):186. doi: 10.1007/s00520-023-07634-5 .
[2] UGUREL S, PF?HLER C, GUTZMER R. Cutaneous adverse events to systemic anticancer therapies : Hand-foot syndrome and nail changes[J]. Dermatologie (Heidelb), 2024,75(6):451-458. doi: 10.1007/s00105-024-05351-6 .
[3] BAJPAI J, KAGWADE S, CHANDRASEKHARAN A, et al."Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia"[J]. Breast, 2020,49:187-193.doi: 10.1016/j.breast.2019.12.004 .
[4] NANGIA J, WANG T, OSBORNE C, et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial[J]. JAMA, 2017,317(6):596-605. doi: 10.1001/jama.2016.20939 .
[5] RICE B A, VERHOEVE E S, DELUCA A N, et al. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy[J]. Breast Cancer Res Treat, 2018,167(1):117-122. doi: 10.1007/s10549-017-4506-z .
[6] CARTON E, BLAS A M, PERRET C, et al. Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: A randomized pilot study[J]. Support Care Cancer, 2024,32(7):410.doi: 10.1007/s00520-024-08579-z .
[7] SHAH V V, WIKRAMANAYAKE T C, DELCANTO G M, et al. Scalp hypothermia as a preventative measure for chemotherapy-induced alopecia: A review of controlled clinical trials[J]. J Eur Acad Dermatol Venereol, 2018,32(5):720-734.doi: 10.1111/jdv.14612 .
[8] 胡智慧,巴根那,李冀,等. 中医治疗对乳腺癌化疗患者的增效与减毒作用研究进展[J]. 医学综述, 2019,25(13):2674-2678.doi:10.3969/j.issn.1006-2084.2019.13.035
[9] 金丹,姜大庆. 乳腺癌术后中医药治疗概况[J]. 实用中医内科杂志, 2017,31(2):86-87.doi:10.13729/j.issn.1671-7813. 2017. 02.33 .
[10] HENRIQUES A C, RIBEIRO D, PEDROSA J, et al. Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution[J]. Cancer Lett, 2019,440-441:64-81.doi: 10.1016/j.canlet.2018.10.005 .
[11] VANN K R, OVIATT A A, OSHEROFF N. Topoisomerase Ⅱ Poisons: Converting Essential Enzymes into Molecular Scissors[J]. Biochemistry, 2021,60(21):1630-1641.doi: 10.1021/acs.biochem.1c00240 .
[12] GAO Q, ZHOU G, LIN S J, et al. How chemotherapy and radiotherapy damage the tissue: Comparative biology lessons from feather and hair models[J]. Exp Dermatol, 2019,28(4):413-418.doi: 10.1111/exd.13846 .
[13] SREEDHAR A, AGUILERA-AGUIRRE L, SINGH K K. Mitochondria in skin health, aging, and disease[J]. Cell Death Dis, 2020,11(6):444.doi: 10.1038/s41419-020-2649-z .
[14] CHIN H S, CHENG J, HSU S H, et al. MCL-1 safeguards activated hair follicle stem cells to enable adult hair regeneration[J]. Nat Commun, 2025,16(1):2829. doi: 10.1038/s41467-025-58150-5 .
[15] DU F, LI J, ZHANG S, et al. Oxidative stress in hair follicle development and hair growth: Signalling pathways, intervening mechanisms and potential of natural antioxidants[J]. J Cell Mol Med, 2024,28(12):e18486.doi: 10.1111/jcmm.18486 .
[16] BASHIR D J, MANZOOR S, SARFARAJ M, et al. Magnoflorine-Loaded Chitosan Collagen Nanocapsules Ameliorate Cognitive Deficit in Scopolamine-Induced Alzheimer's Disease-like Conditions in a Rat Model by Downregulating IL-1β, IL-6, TNF-α, and Oxidative Stress and Upregulating Brain-Derived Neurotrophic Factor and DCX Expressions[J]. ACS Omega, 2023,8(2):2227-2236. doi: 10.1021/acsomega.2c06467 .
[17] INOUE R, ABE H, KONISHI M, et al. Capecitabine-induced hand-foot syndrome does not emerge in the complex regional pain syndrome-affected limb: A case report[J]. Mol Clin Oncol, 2021,15(6):254. doi: 10.3892/mco.2021.2416 .
[18] BROUSSY S. Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease[J]. Pharmaceuticals (Basel), 2024,17(7):959. doi: 10.3390/ph17070959 .
[19] HANG A, FELDMAN S, AMIN A P, et al. Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders[J]. Pharmaceuticals (Basel), 2023,16(8):1140.doi: 10.3390/ph16081140 .
[20] LI L, WANG S, ZHOU W. Balance Cell Apoptosis and Pyroptosis of Caspase-3-Activating Chemotherapy for Better Antitumor Therapy[J]. Cancers (Basel), 2022,15(1):26. doi: 10.3390/cancers15010026 .
[21] GORZELANNY C, MESS C, SCHNEIDER S W, et al. Skin Barriers in Dermal Drug Delivery: Which Barriers Have to Be Overcome and How Can We Measure Them?[J]. Pharmaceutics, 2020,12(7):684.doi: 10.3390/pharmaceutics12070684 .
[22] LI X, YE Y, LIU X, et al. Low-frequency electromagnetic fields promote hair follicles regeneration by injection a mixture of epidermal stem cells and dermal papilla cells[J]. Electromagn Biol Med, 2020, 39(4):251-256.doi: 10.1080/15368378. 2020. 1793165 .
[23] ZHU X, BüHRER C, WELLMANN S. Cold-inducible proteins CIRP and RBM3, a unique couple with activities far beyond the cold[J]. Cell Mol Life Sci, 2016,73(20):3839-3859. doi: 10. 1007/s00018-016-2253-7 .
[24] CHANG W L, KO C H. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications[J]. Cells, 2023,12(6):936.doi: 10.3390/cells12060936 .
[25] 王丰莲. 八珍汤改善乳腺癌化疗患者毛发超微结构的研究[J]. 实用药物与临床, 2018, 21(7): 794-797.doi: 10.14053/j.Cnki.Ppcr.201807018 .
[26] 陈前军,裴晓华. 早期乳腺癌中医辨证内治专家共识[J]. 现代中医临床, 2020,27(3):5-8.doi:10.3969/j.issn.2095-6606. 2020. 03.002 .
[27] 刘益铭,李秋华,梁丽喆,等. 乳腺癌痰瘀互结的病理、病机及治疗[J]. 世界中医药,2021,16(21):3127-3130.doi: 10.3969/j.issn.1673-7202.2021.21.004 .
[28] 蔡丽珍,白瑞娜,张路,等. 基于“痰夹瘀血”理论探讨乳腺癌相关淋巴水肿因机治疗[J]. 陕西中医,2023,44(10):1420-1423.doi: 10.3969/j.issn.1000-7369.2023.10.019 .
[29] AUVINEN P K, M?H?NEN U A, SOININEN K M, et al. The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia[J]. Tumori, 2010,96(2):271-275.doi: 10.1177/030089161009600214 .
[30] ALESSANDRINI A, STARACE M, CERè G, et al. Management and Outcome of Taxane-Induced Nail Side Effects: Experience of 79 Patients from a Single Centre[J]. Skin Appendage Disord, 2019,5(5):276-282.doi: 10.1177/030089161009600214 .
[31] SCOTTé F, TOURANI J M, BANU E, et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand[J]. J Clin Oncol, 2005,23(19):4424-4429. doi: 10.1200/JCO.2005.15.651 .
[32] SCOTTé F, BANU E, MEDIONI J, et al. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot[J]. Cancer, 2008,112(7):1625-1631.doi: 10.1002/cncr.23333 .
[33] DUNNILL C, IBRAHEEM K, PEAKE M, et al. Cooling-mediated protection from chemotherapy drug-induced cytotoxicity in human keratinocytes by inhibition of cellular drug uptake[J]. PLoS One, 2020,15(10):e0240454. doi: 10.1371/journal.pone. 0240454 .
[34] KOMEN M M, SMORENBURG C H, VAN DEN HURK C J, et al. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia[J]. Oncologist, 2013,18(7):885-891. doi: 10.1634/theoncologist.2012-0332 .
[35] BITTO F F, K?NIG A, PHAN-BREHM T, et al. EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients[J]. Breast Care (Basel), 2020,15(2):171-177. doi: 10. 1159/000501393 .
[36] SMETANAY K, JUNIO P, FEI?T M, et al. COOLHAIR: A prospective randomized trial to investigate the efficacy and tolerability of scalp cooling in patients undergoing (neo)adjuvant chemotherapy for early breast cancer[J]. Breast Cancer Res Treat, 2019,173(1):135-143.doi: 10.1007/s10549-018-4983-8 .
[37] VAN DEN HURK C J, BREED W P, NORTIER J W. Short post-infusion scalp cooling time in the prevention of docetaxel-induced alopecia[J]. Support Care Cancer, 2012,20(12):3255-3260. doi: 10.1007/s00520-012-1465-0 .
[38] KATE S, PATIL R, PATHAN D, et al. Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia- A single center prospective study[J]. Cancer Treat Res Commun, 2021,26:100280. doi: 10.1016/j.ctarc.2020.100280 .
[39] KEIM S, HEMPEL L, EBNER F, et al. Scalp Cooling for Prevention of Chemotherapy-Induced Alopecia for Women and Men with Various Cancer Entities: A Two-Year Survey of an Outpatient Cancer Center in Germany[J]. Oncol Res Treat, 2022,45(7/8):395-399. doi: 10.1159/000523759 .
[40] LEE V G H, LOH J, HUI F, et al. Scalp cooling therapy for chemotherapy-induced hair loss in patients with breast or gynecological cancers-an Asian tertiary institution experience[J]. Support Care Cancer, 2024,32(11):762.doi: 10.1007/s00520-024-08940-2 .
[41] ORLANDO L, LOPARCO D, FEDELE P, et al. Final results of a prospective study of scalp cooling in preventing chemotherapy-induced alopecia[J]. Future Oncol, 2019,15(29):3337-3344.doi: 10.2217/fon-2019-0066 .
[42] GIANOTTI E, RAZZINI G, BINI M, et al. Scalp Cooling in Daily Clinical Practice for Breast Cancer Patients Undergoing Curative Chemotherapy: A Multicenter Interventional Study[J]. Asia Pac J Oncol Nurs, 2019,6(3):277-282. doi: 10.4103/apjon.apjon_4_19 .
[43] VAN DEN HURK C J, PEERBOOMS M, VAN DE POLL-FRANSE L V, et al. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients-results of the Dutch Scalp Cooling Registry[J]. Acta Oncol, 2012,51(4):497-504.doi: 10.3109/0284186X.2012.658966 .
[44] KOMEN M M C, VAN DEN HURK C J G, NORTIER J W R, et al. Prolonging the duration of post-infusion scalp cooling in the prevention of anthracycline-induced alopecia: A randomised trial in patients with breast cancer treated with adjuvant chemotherapy[J]. Support Care Cancer, 2019,27(5):1919-1925. doi: 10. 1007/s00520-018-4432-6 .
[45] VILLARREAL-GARZA C, MESA-CHAVEZ F, GARZA-LEDEZMA M R A, et al. Impact of chemotherapy regimen and sequence on the effectiveness of scalp cooling for alopecia prevention[J]. Breast Cancer Res Treat, 2021,185(2):453-458. doi: 10.1007/s10549-020-05968-w .
[46] RIDDERHEIM M, BJURBERG M, GUSTAVSSON A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: A pilot study of a new digitized scalp-cooling system used in 74 patients[J]. Support Care Cancer, 2003,11(6):371-7. doi: 10.1007/s00520-003-0451-y .
[47] 中国医药教育协会烧伤专业委员会. 冻伤早期的临床诊疗全国专家共识[J]. 中华损伤与修复杂志(电子版),2022,17(1):1-6.doi: 10.3877/cma.j.issn.1673-9450.2022.01.001 .
[48] ELSTAD M, ZILAKOS I, BERGERSEN T K. Oscillatory pattern of acral skin blood flow within thermoneutral zone in healthy humans[J]. Physiol Meas, 2017,38(5):848-859. doi: 10.1088/1361-6579/aa5fee .
[49] INGRASSIA J P, STEIN J A, LEVINE A, et al. Diagnosis and Management of Acral Pigmented Lesions[J]. Dermatol Surg J 2023,49(10):926-931. doi: 10.1097/DSS.0000000000003891 .
[50] KLANIDHI K B, MONIAN S A, CHAKRAWARTY A. Acral vascular syndrome Lennert type T cell lymphoma-a case report[J]. J Egypt Natl Canc Inst, 2021,33(1):8.doi: 10.1186/s43046-021-00063-7 .
[51] 李忠友, 蒋文涛, 范海冬, 等. 全身体表血管热扩张诱导血流重分配数值研究[C]//中国力学大会-2021+1论文集编委会. 中国力学大会- 2021+1 论文集(第五册). 成都: 四川大学出版社, 2022: 207.
Outlines

/